Similarly, Mitsuyoshi et al. (38) found increased levels of ACACA gene expression in patients with MASLD with simple steatosis and MASH, whereas ACACB mRNA levels were not accessed in this study (38). This evidence concerns the gene ACACA and metabolic dysfunction-associated steatotic liver disease.